Will India Figure In First-Wave Markets For Sun's Ilumya?
Sun’s Ilumya is available in the US and Europe, with China now on the launch radar as well. Scrip examines whether the firm’s home turf India should also be among the early markets for the novel psoriasis asset, amid pressure to maintain the 'price line'.